COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | ||||
|---|---|---|---|---|---|---|
Feb. 13, 2025 |
Mar. 28, 2022 |
Sep. 30, 2025 |
Sep. 30, 2025 |
May 13, 2025 |
Dec. 31, 2024 |
|
| Subsidiary, Sale of Stock [Line Items] | ||||||
| Shares outstanding | 49,525,970 | 49,525,970 | 2,929,000 | 27,601,767 | ||
| Shares to be issued | 490,000,000 | 490,000,000 | 490,000,000 | |||
| Shares issued | 49,525,970 | 49,525,970 | 27,601,767 | |||
| Forward purchase agreement liability | $ 49,034 | |||||
| Forward purchase agreement liability | $ 9,901 | 9,901 | $ 0 | |||
| Instaprin Pharmaceuticals Inc [Member] | ||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||
| Assets acquired | $ 3,628,325 | |||||
| Business acquistion percentage | 20.00% | |||||
| Transaction costs | $ 5,000,000 | |||||
| Business acquistion description | 10% from sales thereafter until the entire contingent purchase price obligation is satisfied. Additionally, ten percent (10%) of the Company’s equity was to be delivered at Closing, in proportion to their equity holdings in the Company, to be issued to a Trustee for the former Instaprin Shareholders, along with an additional ten percent (10%) of the Company’s equity to be issued to Instaprin’s service providers, pursuant to a stock incentive plan to be adopted. | |||||
| Purchase Agreement [Member] | ||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||
| Forward purchase agreement liability | 49,034 | |||||
| change in fair value of derivatives | 39,384 | 39,133 | ||||
| Forward purchase agreement liability | $ 9,901 | $ 9,901 | ||||
| Purchase Agreement [Member] | Arena Business Solutions Global SPC II Ltd [Member] | ||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||
| Number of shares issued | 100,000,000 | |||||
| Shares to be issued | 2,000,000 | |||||
| Shares issued | 893,473 | |||||
| Private Placement Warrants [Member] | ||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||
| Shares outstanding | 9,763,333 |